Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for potassium canrenoate
Most Correlated Studies
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
- Broad Connectivity Map (CMAP 2.0) compound database
Most Relevant Literature
- Antigenotoxic effect of the Plumbago zeylanica extract against the genotoxic damage induced by potas…
- Population pharmacokinetic model of canrenone after intravenous administration of potassium canrenoa…
- Effect of spironolactone, potassium canrenoate, and their common metabolite canrenone on Dimension V…
- Abbott ARCHITECT clinical chemistry and immunoassay systems: digoxin assays are free of interference…
- Interactions of enhanced urocortin 2 and mineralocorticoid receptor antagonism in experimental heart…
Most Relevant Clinical Trials
- Potassium Canrenoate in Brain-dead Organ Donors: Randomized Controlled Clinical Trial
- Clinical Efficacy of Potassium Canrenoate in Sinus Rhythm Restoration Among Patients With Atrial Fib…
- Potassium Reduction Initiative to Optimize RAAS Inhibition Therapy With Sodium Zirconium Cyclosilica…
- Mineralocorticoid Receptor Antagonist and Pulmonary Fibrosis in COVID-19.
- Early Mineralocorticoid Receptor Antagonist Treatment to Reduce Myocardial Infarct Size
